ANDA 78345, held by Amneal Pharms. Prednisolone Sodium Phosphate.
As of Nov 16, 2026, ANDA 78345 (Prednisolone Sodium Phosphate), held by Amneal Pharms, was first approved by FDA on Mar 10, 2009, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 10, 2009 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Prednisolone Sodium PhosphateEQ 15MG BASE/5ML ยท solution;oral | Prednisolone Sodium Phosphate | Discontinued |
| Jun 13, 2014 | Supplement 6Manufacturing | Approved | None posted |
| Mar 10, 2009 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters